Welcome to Visited Lingnan Modern Clinics In Surgery, Today is

Lingnan Modern Clinics in Surgery ›› 2020, Vol. 20 ›› Issue (03): 404-406.DOI: 10.3969/j.issn.1009-976X.2020.03.032

• Review • Previous Articles     Next Articles

Advances in research on anti-tumor mechanism of dihydromyricetin

LI Zuo-biao, JIANG Lian-gui, LI Ming-yi   

  1. Department of Hepatobiliary Surgery, First Affiliated Hospital, Guangdong Medical University, Zhanjiang, Guangdong 524023, China
  • Contact: LI Mingyi,zjlmy@163.com

二氢杨梅素的抗肿瘤机制研究进展

李作标, 蒋梁贵, 李明意*   

  1. 广东医科大学第一附属医院肝胆外科,广东湛江 524023
  • 通讯作者: *李明意,Email:zjlmy@163.com

Abstract: Dihydromyricetin (DHM) is a polyphenolic hydroxy dihydroflavanols extracted from the stem and leaf of vine tea.Current pharmacology studies have shown that its anti-tumor effects can significantly inhibit the development of lung cancer, liver cancer, stomach cancer and other cells and induce their apoptosis. Existing studies have shown that the anti-tumor mechanisms of DHM mainly include inhibition of tumor cell cycle, intervention of mitochondrial pathways and regulation of tumor-related signaling pathways.

Key words: dihydromyricetin, mechanism, antuneoplastic

摘要: 二氢杨梅素(Dihydromyricetin,DHM)是从葡萄科植物—藤茶茎叶部中提取出来的多酚羟基双氢黄酮醇类化合物。当代药理学已有的研究表明其抗肿瘤作用,能够明显抑制肺癌、肝癌、胃癌等细胞的发展并诱导其凋亡。现有研究表明DHM抗肿瘤机制主要有抑制肿瘤细胞周期、干预线粒通路以及对肿瘤相关信号通路的调控等途径。

关键词: 二氢杨梅素, 抗肿瘤, 机制

CLC Number: